BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10652244)

  • 1. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
    Chun TY; Gorski J
    Toxicol Appl Pharmacol; 2000 Feb; 162(3):161-5. PubMed ID: 10652244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth.
    Chun TY; Gregg D; Sarkar DK; Gorski J
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2325-30. PubMed ID: 9482884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
    Stahl S; Chun TY; Gray WG
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):41-8. PubMed ID: 9772198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo.
    Steinmetz R; Brown NG; Allen DL; Bigsby RM; Ben-Jonathan N
    Endocrinology; 1997 May; 138(5):1780-6. PubMed ID: 9112368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of estrogen receptor antagonists on pituitary lactotroph proliferation and prolactin release.
    Kansra S; Yamagata S; Sneade L; Foster L; Ben-Jonathan N
    Mol Cell Endocrinol; 2005 Jul; 239(1-2):27-36. PubMed ID: 15950373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
    Wilson VS; Bobseine K; Gray LE
    Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in the expression and action of transforming growth factor beta 1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary.
    Pastorcic M; De A; Boyadjieva N; Vale W; Sarkar DK
    Cancer Res; 1995 Nov; 55(21):4892-8. PubMed ID: 7585526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct actions of estradiol on the anterior pituitary gland are required for hypothalamus-dependent lactotrope proliferation and secretory surges of luteinizing hormone but not of prolactin in female rats.
    Yin P; Kawashima K; Arita J
    Neuroendocrinology; 2002 Jun; 75(6):392-401. PubMed ID: 12065892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphenol-A rapidly promotes dynamic changes in hippocampal dendritic morphology through estrogen receptor-mediated pathway by concomitant phosphorylation of NMDA receptor subunit NR2B.
    Xu X; Ye Y; Li T; Chen L; Tian D; Luo Q; Lu M
    Toxicol Appl Pharmacol; 2010 Dec; 249(2):188-96. PubMed ID: 20858508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional effects of bisphenol A and paraben on the induction of calbindin-D(9K) and progesterone receptor via an estrogen receptor pathway in rat pituitary GH3 cells.
    Kim SM; Jung EM; An BS; Hwang I; Vo TT; Kim SR; Lee SM; Choi KC; Jeung EB
    J Physiol Pharmacol; 2012 Oct; 63(5):445-55. PubMed ID: 23211298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Hydroxytamoxifen-induced cytotoxicity and bisphenol A: competition for estrogen receptors in human breast cancer cell lines.
    Lewis JB; Lapp CA; Schafer TE; Wataha JC; Randol TM; Schuster GS
    In Vitro Cell Dev Biol Anim; 2000 May; 36(5):320-6. PubMed ID: 10937835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells.
    Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R
    Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC; Parsons JA
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells.
    Lamberts SW; Verleun T
    Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1117-23. PubMed ID: 2820746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
    Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assays.
    Kim HS; Han SY; Yoo SD; Lee BM; Park KL
    J Toxicol Sci; 2001 Aug; 26(3):111-8. PubMed ID: 11552294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
    Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
    Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.